Postoperative coagulopathy among otherwise healthy pediatric patients undergoing open craniosynostosis repair: a

Shiri Zarour1, Shlomi Constantini2, Jonathan Roth2

  • 1Division of Anesthesia, Intensive Care, and Pain Management, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel.

Insights

Routine transfusion of non-red blood cell products is not necessary for healthy pediatric patients experiencing significant blood loss during craniosynostosis surgery. Packed red blood cell transfusions alone are sufficient for safe management, preventing coagulopathy.

Area of Science:

  • Pediatric Surgery
  • Hematology
  • Anesthesiology

Background:

  • Significant intra-operative blood loss and subsequent transfusions can lead to coagulopathy.
  • The necessity of routine non-red blood cell (non-RBC) blood product transfusions in pediatric patients with substantial blood loss is debated.
  • Potential adverse effects exist from both coagulopathy and blood product administration.

Purpose of the Study:

  • To evaluate the need for routine non-RBC blood product transfusions in healthy pediatric patients undergoing open craniosynostosis surgery with significant intra-operative blood loss.
  • To assess the safety and efficacy of managing significant blood loss solely with packed red blood cells (pRBCs) and intravenous fluids.

Main Methods:

  • Retrospective cohort study of 457 otherwise healthy pediatric patients undergoing open craniosynostosis surgery between 2010 and 2021.
  • Patients were transfused exclusively with pRBCs.
  • Analysis of postoperative coagulopathy incidence, transfusion rates, and hospital/ICU length of stay (LOS).

Main Results:

  • A low incidence of significant postoperative coagulopathy was observed (7.4%).
  • No statistically significant difference in coagulopathy was found between patients receiving different volumes of pRBCs.
  • Hospital LOS and ICU LOS were not clinically significantly impacted by pRBC transfusion volumes.

Conclusions:

  • Open craniosynostosis surgery serves as a valid model for studying coagulopathy in pediatric patients with significant blood loss.
  • In healthy pediatric patients, significant intra-operative blood loss can be safely managed with intravenous fluids and pRBC transfusion alone.
  • Routine non-RBC blood product transfusion is not indicated in this patient population, minimizing risks associated with unnecessary transfusions.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
16
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
223